Start typing to retrieve search suggestions. When suggestions are available use up and down arrows to review and ENTER to select. Continue typing to refine.
Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
Trusted Information Creator
Certified November 2025
{arrow_up} Back to top

Yorvipath 420 micrograms/1.4 mL solution for injection in pre filled pen {equilateral_black_triangle}

Active Ingredient:
palopegteriparatide
Company:  
Ascendis Pharma UK Limited See contact details
ATC code: 
H05AA05
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL)
{arrow_left}
{arrow_right}
The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine.
{info_black}
Last updated on emc: 05 Jul 2024

{equilateral_black_triangle} This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information.

{pdf} View or print the patient leaflet as PDF
Ascendis Pharma UK Limited
Company image
Address
Templar House, 81-87 High Holborn, London, WC1V 6DF, UK
Telephone
+44 (0)7969 628 113
Medical Information Direct Line
+44 (0)7969 628 113
Medical Information e-mail
[email protected]
WWW
www.ascendispharma.com